The PIA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis

International Angiology

Volumn 20, Issue 2, 2001, Pages 148-151

  Renner, W ^a   Winkler, M ^a   Hoffman, C ^a   Koppel H ^a   Seinost, G ^a   Brodmann, M ^a   Pilger, E ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Platelet glycoprotein GPIIb IIIa complex; Polymorphism; Risk factors; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; LEUCINE; MEMBRANE RECEPTOR; PROLINE; PROTEIN SUBUNIT; PROTHROMBIN; VON WILLEBRAND FACTOR; 1A ALLOANTIGEN, HUMAN; BLOOD CLOTTING FACTOR 5; EPITOPE; HUMAN PLATELET ANTIGEN 1B; THROMBOCYTE ANTIGEN;

ADULT; AGE; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CELL ACTIVITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; GENDER; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEPTOR BINDING; RESTRICTION FRAGMENT; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOCYTE; THROMBOCYTE AGGREGATION; AUSTRIA; COMPARATIVE STUDY; GENETICS; LUNG EMBOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; VEIN THROMBOSIS;

ADULT; AGED; ANTIGENS, HUMAN PLATELET; AUSTRIA; CASE-CONTROL STUDIES; EPITOPES; FACTOR V; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROTHROMBIN; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 0034740533     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
2. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study
3. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
4. Association of the platelet P1(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease
5. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
6. Interdonor variability of platelet response to thrombin receptor activation: Influence of PlA2 polymorphism
7. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists
8. PLA2 polymorphism and efficacy of aspirin
9. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): No association with platelet fibrinogen binding
10. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
11. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study
12. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction
13. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction
14. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction
15. Glycoprotein IIIa polymorphism and risk of myocardial infarction
16. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease
17. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis
18. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
19. Platelets